Literature DB >> 21526417

Claudins and cancer stem cells.

Kursad Turksen1.   

Abstract

It is now believed that most epithelial tumors are maintained by a subpopulation of cells called cancer stem cells (CSCs) or tumor initiating cells (TICs) with stem cell-like properties, including self-renewal and multilineage differentiation capacity. Recently new insights into this population have emerged in certain epithelial tumor types, including their Claudin(low) phenotype and its importance to the epithelial-mesenchymal transition (EMT) process. Taken together, CSCs, EMT and Claudins appear to constitute an axis-of-evil in cancer, for which better understanding may lead to new therapeutic platforms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21526417     DOI: 10.1007/s12015-011-9267-1

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  24 in total

1.  Molecular stratification of triple-negative breast cancers.

Authors:  Charles M Perou
Journal:  Oncologist       Date:  2011

2.  Claudin-6: a novel tight junction molecule is developmentally regulated in mouse embryonic epithelium.

Authors:  K Turksen; T C Troy
Journal:  Dev Dyn       Date:  2001-10       Impact factor: 3.780

3.  Predicted expansion of the claudin multigene family.

Authors:  Katsuhiko Mineta; Yasuko Yamamoto; Yuji Yamazaki; Hiroo Tanaka; Yukiyo Tada; Kuniaki Saito; Atsushi Tamura; Michihiro Igarashi; Toshinori Endo; Kosei Takeuchi; Sachiko Tsukita
Journal:  FEBS Lett       Date:  2011-01-26       Impact factor: 4.124

Review 4.  Triple negative breast cancer: from molecular portrait to therapeutic intervention.

Authors:  Pietro Carotenuto; Cristin Roma; Anna Maria Rachiglio; Gerardo Botti; Amelia D'Alessio; Nicola Normanno
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2010       Impact factor: 1.807

5.  The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells.

Authors:  Ofelia M Martínez-Estrada; Albert Cullerés; Francesc X Soriano; Hector Peinado; Victoria Bolós; Fernando O Martínez; Manuel Reina; Amparo Cano; Myriam Fabre; Senén Vilaró
Journal:  Biochem J       Date:  2006-03-01       Impact factor: 3.857

6.  Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes.

Authors:  Joseph H Taube; Jason I Herschkowitz; Kakajan Komurov; Alicia Y Zhou; Supriya Gupta; Jing Yang; Kimberly Hartwell; Tamer T Onder; Piyush B Gupta; Kurt W Evans; Brett G Hollier; Prahlad T Ram; Eric S Lander; Jeffrey M Rosen; Robert A Weinberg; Sendurai A Mani
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

7.  Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.

Authors:  Bryan T Hennessy; Ana-Maria Gonzalez-Angulo; Katherine Stemke-Hale; Michael Z Gilcrease; Savitri Krishnamurthy; Ju-Seog Lee; Jane Fridlyand; Aysegul Sahin; Roshan Agarwal; Corwin Joy; Wenbin Liu; David Stivers; Keith Baggerly; Mark Carey; Ana Lluch; Carlos Monteagudo; Xiaping He; Victor Weigman; Cheng Fan; Juan Palazzo; Gabriel N Hortobagyi; Laura K Nolden; Nicholas J Wang; Vicente Valero; Joe W Gray; Charles M Perou; Gordon B Mills
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

8.  Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society.

Authors:  Hirotaka Iwase; Junichi Kurebayashi; Hitoshi Tsuda; Tomohiko Ohta; Masafumi Kurosumi; Kazuaki Miyamoto; Yutaka Yamamoto; Takuji Iwase
Journal:  Breast Cancer       Date:  2009-05-23       Impact factor: 4.239

9.  A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts.

Authors:  M Furuse; H Sasaki; K Fujimoto; S Tsukita
Journal:  J Cell Biol       Date:  1998-10-19       Impact factor: 10.539

10.  Claudin 7 expression and localization in the normal murine mammary gland and murine mammary tumors.

Authors:  Brigitte Blackman; Tanya Russell; Steven K Nordeen; Daniel Medina; Margaret C Neville
Journal:  Breast Cancer Res       Date:  2005-01-17       Impact factor: 6.466

View more
  11 in total

1.  Expression of Tight Junction Components in Hepatocyte-Like Cells Differentiated from Human Embryonic Stem Cells.

Authors:  Boglárka Erdélyi-Belle; György Török; Ágota Apáti; Balázs Sarkadi; Zsuzsa Schaff; András Kiss; László Homolya
Journal:  Pathol Oncol Res       Date:  2015-04-07       Impact factor: 3.201

2.  Methods to examine tight junction physiology in cancer stem cells: TEER, paracellular permeability, and dilution potential measurements.

Authors:  Michael Buchert; Kursad Turksen; Frédéric Hollande
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

Review 3.  The malignant social network: cell-cell adhesion and communication in cancer stem cells.

Authors:  James S Hale; Meizhang Li; Justin D Lathia
Journal:  Cell Adh Migr       Date:  2012-07-01       Impact factor: 3.405

4.  miR-1303 targets claudin-18 gene to modulate proliferation and invasion of gastric cancer cells.

Authors:  Shi-jie Zhang; Jian-fang Feng; Lei Wang; Wei Guo; Yu-wen Du; Liang Ming; Guo-qiang Zhao
Journal:  Dig Dis Sci       Date:  2014-03-20       Impact factor: 3.199

Review 5.  Emerging roles of claudins in human cancer.

Authors:  Mi Jeong Kwon
Journal:  Int J Mol Sci       Date:  2013-09-04       Impact factor: 5.923

6.  Down-regulation of claudin-18 is associated with the proliferative and invasive potential of gastric cancer at the invasive front.

Authors:  Tadayuki Oshima; Jing Shan; Takuya Okugawa; Xin Chen; Kazutoshi Hori; Toshihiko Tomita; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

7.  Targeting claudin-3 suppresses stem cell-like phenotype in nonsquamous non-small-cell lung carcinoma.

Authors:  Lin Ma; Wu Yin; Heliang Ma; Ihab Elshoura; Lan Wang
Journal:  Lung Cancer Manag       Date:  2019-02-26

8.  DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression.

Authors:  Jia-En Wu; Yi-Ying Wu; Chia-Hao Tung; Yao-Tsung Tsai; Hsuan-Yu Chen; Yuh-Ling Chen; Tse-Ming Hong
Journal:  Theranostics       Date:  2020-07-11       Impact factor: 11.556

Review 9.  Claudin-1, A Double-Edged Sword in Cancer.

Authors:  Ajaz A Bhat; Najeeb Syed; Lubna Therachiyil; Sabah Nisar; Sheema Hashem; Muzafar A Macha; Santosh K Yadav; Roopesh Krishnankutty; Shanmugakonar Muralitharan; Hamda Al-Naemi; Puneet Bagga; Ravinder Reddy; Punita Dhawan; Anthony Akobeng; Shahab Uddin; Michael P Frenneaux; Wael El-Rifai; Mohammad Haris
Journal:  Int J Mol Sci       Date:  2020-01-15       Impact factor: 5.923

10.  Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling.

Authors:  Chang Xu; Yu-Han Ding; Kun Wang; Mengdi Hao; Huimin Li; Lei Ding
Journal:  J Transl Med       Date:  2021-07-19       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.